The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / CAF_2012_RBFIE-FBL_V01_M / variable [F11]
impact_evaluation

Health Results-Based Financing Impact Evaluation 2012, Health Facility Baseline Survey

Central African Republic, 2012
Get Microdata
Reference ID
CAF_2012_RBFIE-FBL_v01_M
DOI
https://doi.org/10.48529/w8rv-dk07
Producer(s)
Damien de Walque
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
Oct 17, 2014
Last modified
Jun 16, 2015
Page views
235552
Downloads
67835
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Data files
  • F1_Aire de
    Santé (section
    15)
  • F1_Disponibilité
    des medicaments
  • F1_Evaluation
    des FOSA
  • F1_Liste des
    personnel(section
    4)
  • F1_Ressource
    humaine
  • F1_Utilisation
    de SNIS(section
    8)
  • F2_Agents de
    santé
  • F3_Oservation
    Directe CPN
  • F4_Observation
    Directe Moins
    de 5ans
  • F5_Sortie de
    CPN
  • F6_Sortie de
    moins de 5ans
  • F7_Sortie Plus
    de 5ans

Type de médicament administrer (f6_02_19_4)

Data file: F6_Sortie de moins de 5ans

Overview

Valid: 75
Invalid: 0
Type: Discrete
Start: 244
End: 263
Width: 20
Range: -
Format: character

Questions and instructions

Literal question
Quels médicaments étaient admnistrés ?
Categories
Value Category Cases
AAS 1
1.3%
AAS 500MG 1
1.3%
ABENDAZOL 1
1.3%
ALBENDAZOLE 1
1.3%
ARTHEMETER 1
1.3%
Albendazole 1
1.3%
Albendazole 400mg 1
1.3%
Amoxi 1
1.3%
Amoxy 1
1.3%
Ampi 1g 1
1.3%
Ampicyline 1
1.3%
Aspirine 500mg 1
1.3%
Benzyl 1
1.3%
CIPROFLOXACINE 1
1.3%
COARTEM 1
1.3%
COTON ET ALCOOL 1
1.3%
COTON HYD. 1
1.3%
CTM 1
1.3%
DIPYRONE 2.5 INJ 1
1.3%
Dexa 1
1.3%
Dexa 2amp 1
1.3%
Erythromycine 1
1.3%
FAF 1
1.3%
FAT 1
1.3%
FER 1
1.3%
Imoduim 2
2.7%
MEBENDAZOL 2
2.7%
MEBENDAZOLE 4
5.3%
METRO 1
1.3%
METRONIDAZOLE 1
1.3%
Mebendazole 1
1.3%
Mebendazole 100mg 2
2.7%
Métromidazole 1
1.3%
PARA 2
2.7%
SERING 3
4%
SERINGUE 1
1.3%
SPARADRAP 1
1.3%
SRO 4
5.3%
SRO à vol 1
1.3%
SUU 5CC 2 1
1.3%
SVV 5ml 1
1.3%
Sering 1
1.3%
Seringue 1
1.3%
Seringue 5cc 1
1.3%
TETRA 1% 1
1.3%
TETRACYCLINE 1% 1
1.3%
VB12 1AMP 1
1.3%
VERMOX 2
2.7%
VIT 2
2.7%
Vermox 100mg 1
1.3%
ZENTEL 2
2.7%
amoxi 250mg 1
1.3%
dexamethazol 1
1.3%
dipirone 1
1.3%
mebendazole 1
1.3%
metoclapramine 1
1.3%
multivitamine,fer,su 1
1.3%
sERINGUE 1
1.3%
sro 1
1.3%
suu5cc 1
1.3%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question post text
Énumérateurs destinés à contrôler les médicaments mentionnés sur l'ordonnance pour confirmation
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.